+4,437.1%
SNDK vs CHTR
-59.2%
+4,496.2%
-56.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | CHTR | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.5% | +3.7% | -7.2% | -3.1% |
| 7D | -6.1% | -4.1% | -2.0% | -6.4% |
| 30D | +21.5% | -3.0% | +24.5% | +21.6% |
| 3M | -13.2% | +4.8% | -18.0% | -11.4% |
| 6M | +149.2% | -35.0% | +184.2% | +163.1% |
| YTD | +588.1% | -30.2% | +618.2% | +596.6% |
| 1Y | +1,837.5% | -44.8% | +1,882.3% | +2,044.6% |
| All | +4,437.1% | -59.2% | +4,496.2% | +5,920.3% |
Cumulative growth
Daily Returns
Daily percentage return beside CHTR.
Daily Out/Under-Performance
Portfolio return minus CHTR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CHTR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded CHTR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling